 Karin Payne
Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Growth Plate | 9 | 2026 | 39 | 2.260 |
Why?
| | Regenerative Medicine | 4 | 2022 | 50 | 1.940 |
Why?
| | Chitosan | 8 | 2024 | 38 | 1.940 |
Why?
| | Osteogenesis | 9 | 2024 | 208 | 1.630 |
Why?
| | Tibia | 4 | 2023 | 176 | 1.240 |
Why?
| | Hydrogels | 10 | 2026 | 700 | 0.970 |
Why?
| | Salter-Harris Fractures | 4 | 2026 | 14 | 0.910 |
Why?
| | Chondrogenesis | 8 | 2022 | 88 | 0.900 |
Why?
| | Biocompatible Materials | 6 | 2022 | 435 | 0.850 |
Why?
| | Alginates | 3 | 2024 | 49 | 0.830 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2020 | 557 | 0.760 |
Why?
| | Tibial Fractures | 1 | 2023 | 72 | 0.730 |
Why?
| | Bone Resorption | 2 | 2022 | 80 | 0.730 |
Why?
| | Rats, Sprague-Dawley | 9 | 2026 | 2527 | 0.710 |
Why?
| | Musculoskeletal System | 1 | 2022 | 49 | 0.690 |
Why?
| | Wound Healing | 3 | 2020 | 351 | 0.650 |
Why?
| | Cartilage | 8 | 2026 | 198 | 0.640 |
Why?
| | Tissue Engineering | 11 | 2026 | 442 | 0.620 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2018 | 59 | 0.610 |
Why?
| | Spinal Fusion | 1 | 2022 | 260 | 0.580 |
Why?
| | Stem Cells | 7 | 2022 | 626 | 0.580 |
Why?
| | Rats | 14 | 2026 | 5597 | 0.570 |
Why?
| | Antibodies | 1 | 2020 | 401 | 0.560 |
Why?
| | Bone Regeneration | 1 | 2017 | 28 | 0.520 |
Why?
| | Bone Development | 1 | 2017 | 52 | 0.510 |
Why?
| | Bone Diseases | 1 | 2017 | 61 | 0.510 |
Why?
| | Dependovirus | 2 | 2013 | 79 | 0.420 |
Why?
| | Transgenes | 2 | 2013 | 189 | 0.410 |
Why?
| | Cell Differentiation | 12 | 2024 | 2050 | 0.400 |
Why?
| | Cartilage, Articular | 6 | 2022 | 343 | 0.390 |
Why?
| | Muscle Cells | 2 | 2010 | 42 | 0.380 |
Why?
| | Animals | 29 | 2026 | 38058 | 0.370 |
Why?
| | Biomimetic Materials | 2 | 2026 | 76 | 0.370 |
Why?
| | Muscle, Skeletal | 7 | 2009 | 1795 | 0.330 |
Why?
| | Doxycycline | 1 | 2011 | 62 | 0.330 |
Why?
| | Hindlimb | 1 | 2011 | 131 | 0.330 |
Why?
| | Bone Morphogenetic Protein 4 | 8 | 2010 | 43 | 0.320 |
Why?
| | Disease Models, Animal | 8 | 2026 | 4557 | 0.320 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 138 | 0.310 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 175 | 0.310 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 266 | 0.300 |
Why?
| | Mechanical Phenomena | 2 | 2020 | 80 | 0.290 |
Why?
| | Bone Marrow Cells | 1 | 2010 | 320 | 0.280 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2010 | 380 | 0.280 |
Why?
| | Cartilage Diseases | 2 | 2018 | 45 | 0.270 |
Why?
| | Polyelectrolytes | 2 | 2024 | 15 | 0.260 |
Why?
| | Multipotent Stem Cells | 1 | 2007 | 21 | 0.260 |
Why?
| | Adult Stem Cells | 1 | 2007 | 39 | 0.250 |
Why?
| | Regeneration | 4 | 2021 | 197 | 0.250 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2026 | 15 | 0.240 |
Why?
| | Femur | 2 | 2023 | 250 | 0.240 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2007 | 339 | 0.220 |
Why?
| | Iridoids | 2 | 2022 | 4 | 0.220 |
Why?
| | Rabbits | 3 | 2022 | 648 | 0.210 |
Why?
| | Genetic Therapy | 5 | 2013 | 313 | 0.210 |
Why?
| | Cells, Cultured | 8 | 2018 | 4154 | 0.200 |
Why?
| | Delayed-Action Preparations | 1 | 2024 | 183 | 0.200 |
Why?
| | Genetic Vectors | 3 | 2013 | 337 | 0.200 |
Why?
| | Gene Transfer Techniques | 4 | 2011 | 185 | 0.200 |
Why?
| | Bone Morphogenetic Proteins | 4 | 2007 | 142 | 0.190 |
Why?
| | RANK Ligand | 1 | 2022 | 26 | 0.190 |
Why?
| | Osteoprotegerin | 1 | 2022 | 22 | 0.190 |
Why?
| | Male | 15 | 2026 | 72315 | 0.190 |
Why?
| | Osteoclasts | 1 | 2022 | 52 | 0.180 |
Why?
| | RNA, Small Interfering | 1 | 2024 | 635 | 0.180 |
Why?
| | Transfection | 2 | 2004 | 940 | 0.170 |
Why?
| | Permeability | 1 | 2020 | 168 | 0.150 |
Why?
| | Rheology | 1 | 2020 | 94 | 0.150 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 77 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2022 | 375 | 0.150 |
Why?
| | Cross-Linking Reagents | 1 | 2020 | 207 | 0.150 |
Why?
| | Lower Extremity | 1 | 2023 | 438 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2008 | 790 | 0.140 |
Why?
| | Stifle | 1 | 2018 | 14 | 0.140 |
Why?
| | Sex | 1 | 2007 | 4 | 0.130 |
Why?
| | Muscular Dystrophy, Animal | 1 | 2007 | 10 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 479 | 0.130 |
Why?
| | Pluripotent Stem Cells | 1 | 2007 | 84 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2018 | 294 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2019 | 276 | 0.120 |
Why?
| | DNA | 2 | 2004 | 1463 | 0.120 |
Why?
| | Muramidase | 1 | 2016 | 67 | 0.120 |
Why?
| | Osteoarthritis | 1 | 2008 | 196 | 0.120 |
Why?
| | Bone and Bones | 2 | 2005 | 314 | 0.120 |
Why?
| | Nanotechnology | 2 | 2004 | 126 | 0.120 |
Why?
| | Calcium | 2 | 2020 | 1183 | 0.120 |
Why?
| | Humans | 16 | 2023 | 144759 | 0.110 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 223 | 0.110 |
Why?
| | Child | 3 | 2023 | 22633 | 0.110 |
Why?
| | Transcriptome | 1 | 2022 | 1045 | 0.110 |
Why?
| | Injections, Intra-Articular | 2 | 2013 | 58 | 0.110 |
Why?
| | Orthopedics | 1 | 2007 | 169 | 0.110 |
Why?
| | Luciferases | 2 | 2013 | 152 | 0.110 |
Why?
| | Injections | 3 | 2026 | 196 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2010 | 5992 | 0.100 |
Why?
| | Stem Cell Transplantation | 2 | 2009 | 191 | 0.100 |
Why?
| | Chitin | 1 | 2003 | 8 | 0.100 |
Why?
| | Female | 8 | 2023 | 78271 | 0.100 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 380 | 0.090 |
Why?
| | Joint Diseases | 1 | 2013 | 62 | 0.090 |
Why?
| | Joints | 1 | 2013 | 107 | 0.090 |
Why?
| | Bone Substitutes | 1 | 2002 | 26 | 0.090 |
Why?
| | Emulsions | 2 | 2022 | 57 | 0.090 |
Why?
| | Tetracycline | 1 | 2011 | 13 | 0.090 |
Why?
| | Transduction, Genetic | 4 | 2009 | 133 | 0.080 |
Why?
| | Mice | 8 | 2010 | 18339 | 0.080 |
Why?
| | Chromones | 1 | 2010 | 42 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 983 | 0.080 |
Why?
| | Cell Survival | 2 | 2010 | 1098 | 0.080 |
Why?
| | Flavonoids | 1 | 2010 | 87 | 0.080 |
Why?
| | Morpholines | 1 | 2010 | 128 | 0.080 |
Why?
| | Glycosaminoglycans | 1 | 2010 | 74 | 0.080 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 416 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 405 | 0.080 |
Why?
| | Choristoma | 1 | 2009 | 21 | 0.080 |
Why?
| | Imidazoles | 1 | 2010 | 254 | 0.070 |
Why?
| | Trans-Activators | 1 | 2011 | 405 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 74 | 0.070 |
Why?
| | Rats, Nude | 3 | 2009 | 25 | 0.070 |
Why?
| | Cell Lineage | 2 | 2007 | 376 | 0.070 |
Why?
| | Cell Proliferation | 3 | 2010 | 2496 | 0.070 |
Why?
| | Random Allocation | 2 | 2018 | 363 | 0.070 |
Why?
| | MyoD Protein | 1 | 2007 | 31 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2010 | 824 | 0.060 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 208 | 0.060 |
Why?
| | Muscle Development | 1 | 2007 | 116 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2011 | 2608 | 0.060 |
Why?
| | Mice, SCID | 1 | 2007 | 369 | 0.060 |
Why?
| | Pyridines | 1 | 2010 | 605 | 0.060 |
Why?
| | Extracellular Matrix | 2 | 2022 | 553 | 0.060 |
Why?
| | Stress, Mechanical | 2 | 2022 | 494 | 0.060 |
Why?
| | Osteoarthritis, Knee | 1 | 2009 | 279 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2023 | 17066 | 0.050 |
Why?
| | Adolescent | 2 | 2017 | 22428 | 0.050 |
Why?
| | Chondrocytes | 3 | 2017 | 232 | 0.050 |
Why?
| | Cattle | 2 | 2022 | 1000 | 0.050 |
Why?
| | Sex Factors | 1 | 2010 | 2112 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2947 | 0.050 |
Why?
| | Infant | 1 | 2017 | 10034 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2007 | 737 | 0.050 |
Why?
| | Desmin | 2 | 2007 | 24 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3333 | 0.050 |
Why?
| | Child, Preschool | 1 | 2017 | 11787 | 0.050 |
Why?
| | Solvents | 1 | 2022 | 113 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2007 | 1455 | 0.040 |
Why?
| | Signal Transduction | 2 | 2019 | 5226 | 0.040 |
Why?
| | Smad Proteins | 1 | 2019 | 43 | 0.040 |
Why?
| | Ataxins | 1 | 2008 | 5 | 0.040 |
Why?
| | Ataxin-1 | 1 | 2008 | 5 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2018 | 85 | 0.040 |
Why?
| | Mice, Inbred mdx | 1 | 2007 | 12 | 0.030 |
Why?
| | Retroviridae | 2 | 2009 | 101 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8265 | 0.030 |
Why?
| | NIH 3T3 Cells | 2 | 2009 | 148 | 0.030 |
Why?
| | Horses | 1 | 2018 | 201 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2018 | 290 | 0.030 |
Why?
| | Myosin Heavy Chains | 1 | 2007 | 185 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2019 | 842 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 240 | 0.030 |
Why?
| | Gels | 1 | 2016 | 84 | 0.030 |
Why?
| | Arthroscopy | 1 | 2018 | 267 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 592 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2016 | 561 | 0.030 |
Why?
| | Cell Line | 2 | 2005 | 2882 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2008 | 748 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2009 | 1716 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 35875 | 0.020 |
Why?
| | Recovery of Function | 1 | 2007 | 707 | 0.020 |
Why?
| | Young Adult | 1 | 2010 | 14105 | 0.020 |
Why?
| | Cnidaria | 1 | 2002 | 6 | 0.020 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 87 | 0.020 |
Why?
| | Osseointegration | 1 | 2002 | 60 | 0.020 |
Why?
| | Bone Transplantation | 1 | 2002 | 86 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2007 | 1339 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1782 | 0.020 |
Why?
| | Aged | 1 | 2010 | 25913 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2009 | 29 | 0.020 |
Why?
| | Phenazines | 1 | 2009 | 16 | 0.020 |
Why?
| | Hyaline Cartilage | 1 | 2009 | 4 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2009 | 88 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2009 | 93 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2009 | 106 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 199 | 0.020 |
Why?
| | Drug Synergism | 1 | 2009 | 357 | 0.020 |
Why?
| | Solubility | 1 | 2009 | 242 | 0.020 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2007 | 21 | 0.020 |
Why?
| | Molecular Structure | 1 | 2009 | 499 | 0.020 |
Why?
| | Adult | 1 | 2010 | 40449 | 0.020 |
Why?
| | Time Factors | 2 | 2009 | 7173 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2006 | 77 | 0.010 |
Why?
| | Collagen Type II | 1 | 2006 | 54 | 0.010 |
Why?
| | Lac Operon | 1 | 2005 | 44 | 0.010 |
Why?
| | Antigens, Ly | 1 | 2005 | 40 | 0.010 |
Why?
| | Proteoglycans | 1 | 2006 | 110 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2005 | 101 | 0.010 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 45 | 0.010 |
Why?
| | Osteocytes | 1 | 2005 | 24 | 0.010 |
Why?
| | Biomarkers | 2 | 2007 | 4271 | 0.010 |
Why?
| | Antigens, CD34 | 1 | 2005 | 88 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3863 | 0.010 |
Why?
| | Vimentin | 1 | 2005 | 54 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2027 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2007 | 902 | 0.010 |
Why?
| | Myoblasts | 1 | 2005 | 84 | 0.010 |
Why?
| | Biological Assay | 1 | 2005 | 128 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 145 | 0.010 |
Why?
| | Muscles | 1 | 2005 | 333 | 0.010 |
Why?
| | Blotting, Western | 1 | 2005 | 1187 | 0.010 |
Why?
| | Bone Density | 1 | 2005 | 482 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2005 | 1173 | 0.010 |
Why?
| | Fibroblasts | 1 | 2005 | 1034 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2005 | 1166 | 0.010 |
Why?
|
|
Payne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|